It is well understood that breast cancer tissue and cell lines can contain upwards of 50-100-fold higher levels of ErbB2 protein compared to normal tissue and these levels are typically associated with gene amplification and poor prognosis [50,51]. The gene discussed is ERBB2; the disease is breast carcinoma.